test

Nina Kadan-Lottick MD

Associate Professor of Pediatrics (Hematology / Oncology); Medical Director, HEROS Program

Clinical Interests

Late effects of cancer therapy, including osteoporosis, growth failure, neurocognitive deficits, infertility, cardiomyopathy, and second neoplasms; Childhood cancer survivorship; Treatment of acute childhood leukemia and other childhood malignancies; Diagnosis and treatment of hypoglobinopathies; Quality of life of childhood cancer patients; Sarcomas; lymphoma; Brain tumors; Blood disorders; Thrombocytopenia; Hematologic disorders; Immune hematologic disorders


Board Certifications

2000
Hematology-Oncology, Board Certified

Patient Care Locations

 
nina_kadan-lottickfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Chordoma, Desmoid Tumor, Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma, and Soft Tissue A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol (COG 9902)
Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, and Lymphoid Leukemia Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)
Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma, and Brain and Nervous System Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years (COG ACNS0831) (CIRB)
Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer, and Liver Treatment of Children with All Stages of Hepatoblastoma: A Groupwide, Phase III Study (COG AHEP0731) (CIRB)
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma, and Brain and Nervous System ANBL0032: PHASE III RANDOMIZED STUDY OF CHIMERIC ANTIBODY 14.18 (Ch14.18) IN HIGH RISK NEUROBLASTOMA FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL RESCUE

More Clinical Trials...

Edit Profile